US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.58

-0.3500-0.23%

Post-market: 153.90-0.6801-0.44%19:57 EDT

Volume:8.64M

Turnover:1.33B

Market Cap:371.93B

PE:17.20

High:154.90

Open:154.32

Low:152.45

Close:154.93

Loading ...

Overview Company News Filings

Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate

MT Newswires Live

J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study

J&J - Median Overall Survival Not yet Reached With Projected Improvement of More Than One Year Versus Osimertinib

THOMSON REUTERS

Rybrevant® (Amivantamab-Vmjw) Plus Lazcluze™ (Lazertinib) Outperforms Osimertinib With a Significant and Unprecedented Overall Survival Benefit in Patients With Egfr-Mutated Non-Small Cell Lung Cancer

THOMSON REUTERS

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

BRIEF-New Nipocalimab Data And Real-World Research At Aan 2025 Highlight Positive Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis (gMG)

New Nipocalimab Data and Real-World Research at Aan 2025 Highlight Positive Phase 3 Results and Commitment to People Living With Generalized Myasthenia Gravis (Gmg)

THOMSON REUTERS

New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)

Press Release: Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan

Johnson & Johnson Medtech Launches Dualto™ Energy System for Use Across Surgical Treatment Approaches

THOMSON REUTERS

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

FACTBOX-How companies are responding to Trump's tariffs

3 amazing ASX ETFs for beginner investors to buy and hold

ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

Kenvue Faces Activist Pressure: TOMS Capital Management Pushes for Strategic Changes

Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?

Market Chatter: Kenvue Urged by TOMS Capital to Consider Sale, Spinoff of Assets

MT Newswires Live

Here's How to Play JNJ Stock as it Announces $55B US Investment Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JNJ/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":154.58,"timestamp":1745611200000,"preClose":154.93,"halted":0,"volume":8643927,"hourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"delay":0,"floatShares":2402384768,"shares":2406073279,"eps":8.984973,"marketStatus":"Market Closed","change":-0.35,"latestTime":"04-25 16:00:00 EDT","open":154.32,"high":154.9,"low":152.45,"amount":1330911231.6210902,"amplitude":0.015814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.984973,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":154.93,"dividendRate":0.032087,"preHourTrading":{"tag":"盘前","latestPrice":154.26,"preClose":154.93,"latestTime":"09:29 EDT","volume":3621,"amount":560780.2869,"timestamp":1745587772890},"postHourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"volumeRatio":1.033507316421939,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":true,"expireDate":1745553600000,"strike":"155.0","timestamp":1745588586409,"price":0.2,"volume":1994,"amount":39880,"type":"+"}]},"impliedVol":0.2478,"impliedVolPercentile":0.936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2402384768,"roa":"7.74%","roe":"29.45%","lyrEps":5.84306,"volumeRatio":1.033507316421939,"shares":2406073279,"dividePrice":4.96,"high":154.9,"amplitude":0.015814,"preClose":154.93,"low":152.45,"week52Low":140.68,"pbRate":"4.76","psRate":"4.16","week52High":169.99,"institutionHeld":0.6213,"latestPrice":154.58,"eps":8.984973,"divideRate":0.032087,"volume":8643927,"delay":0,"ttmEps":8.984973,"open":154.32,"prevYearClose":144.62,"prevWeekClose":157.47,"prevMonthClose":165.84,"prevQuarterClose":165.84,"fiveDayClose":157.47,"twentyDayClose":163.13,"sixtyDayClose":151.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522387258","title":"Johnson & Johnson Reports Positive Data from Phase 3 Study of Lung Cancer Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522387258","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522387258?lang=en_us&edition=fundamental","pubTime":"2025-03-27 00:37","pubTimestamp":1743007049,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  said Wednesday that results from a phase 3 trial showed that Rybrevant as a conjugate therapy \"significantly extended\" overall survival in certain cancer patients.The drug was studied in combination Lazcluze as first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer, NSCLC, compared with osimertinib and Lazcluze as a monotherapy, according to the statement.Patients treated with the chemotherapy-free regimen of the Rybrevant-Lazcluze combination had a significantly longer overall survival compared with those treated with osimertinib at the study's median follow-up of 37.8 months. Median overall survival has not yet been reached, indicating that the combination therapy's survival benefits extend beyond the measured follow-up period.The company expects median overall survival from the Rybrevant and Lazcluze to surpass the three-year median observed with osimertinib by a year.Johnson & Johnson said the phase 3 study achieved its pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999001440.SGD","LU0882574055.USD","LU0114720955.EUR","LU0912757837.SGD","LU2129689431.USD","LU0345769631.USD","LU0234572021.USD","IE00BSNM7G36.USD","LU2133065610.SGD","BK4592","LU0098860793.USD","BK4534","LU1674673428.USD","IE00B2B36J28.USD","LU1074936037.SGD","LU2430703178.SGD","LU0203345920.USD","LU2129689605.HKD","LU0795875086.SGD","LU1066051225.USD","LU1162221912.USD","LU1066051498.USD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU2112291526.USD","LU0289739699.SGD","IE00BGHQF631.EUR","LU0234570918.USD","LU1221951129.SGD","IE00B1BXHZ80.USD","IE00B7SZLL34.SGD","LU2592432038.USD","LU0058720904.USD","LU0792757196.USD","IE00B42XCP33.USD","LU1778281490.HKD","LU1267930813.SGD","JNJ","LU1244550577.SGD","LU0203347892.USD","LU1032955483.USD","LU0889566641.SGD","LU2505996509.AUD","LU2430703251.USD","LU1066053197.SGD","LU1280957306.USD","LU1674673691.USD","LU1430594728.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2522638286","title":"J&J says Rybrevant/Lazcluze outperforms osimertinib OS in Phase 3 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522638286","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522638286?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:50","pubTimestamp":1743004209,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced results for the “gold standard endpoint in cancer treatment” of overall survival from the Phase 3 MARIPOSA study. Head-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jj-says-rybrevant-lazcluze-outperforms-osimertinib-os-in-phase-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jj-says-rybrevant-lazcluze-outperforms-osimertinib-os-in-phase-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1718418525.SGD","BK4504","BK4534","LU0345769631.USD","LU1066051225.USD","IE00BVYPNV92.GBP","LU1032466523.USD","IE00BJJMRZ35.SGD","LU0345769128.USD","LU0203345920.USD","LU1057294990.SGD","LU0114720955.EUR","LU1066051498.USD","BK4585","LU0098860793.USD","LU1674673428.USD","LU1732800096.USD","LU1280957306.USD","LU2112291526.USD","LU1074936037.SGD","LU0882574055.USD","LU2430703095.HKD","LU1244550577.SGD","JNJ","LU0795875086.SGD","LU1162221912.USD","LU1778281490.HKD","LU1585245621.USD","IE00B19Z3581.USD","IE0002141913.USD","LU1059921491.USD","SG9999002232.USD","BK4559","LU2129689514.USD","IE00B2B36J28.USD","LU1267930813.SGD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0792757196.USD","LU1674673691.USD","LU1935042991.SGD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1261432733.SGD","LU2347655156.SGD","LU2430703178.SGD","IE00B7SZLL34.SGD","BK4581"],"gpt_icon":0},{"id":"2522938435","title":"J&J - Median Overall Survival Not yet Reached With Projected Improvement of More Than One Year Versus Osimertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2522938435","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522938435?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003916,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q91BT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0466842654.USD","LU1196500208.SGD","LU2129689514.USD","LU2347655156.SGD","LU0058720904.USD","LU1267930813.SGD","LU2505996681.GBP","LU0114720955.EUR","LU1914381329.SGD","SG9999002224.SGD","IE00B42XCP33.USD","BK4550","LU0795875169.SGD","LU1074936037.SGD","LU0203347892.USD","LU1585245621.USD","IE00B2B36J28.USD","LU1066051225.USD","LU0234572021.USD","LU0098860793.USD","LU1430594728.SGD","BK4592","BK4568","IE00B4R5TH58.HKD","LU1732799900.SGD","LU1066051498.USD","LU0345770993.USD","LU1061106388.HKD","LU0345770308.USD","IE0009355771.USD","IE00BVYPNW00.USD","IE00BFTCPJ56.SGD","BK4532","LU1066051811.HKD","LU1894683264.USD","BK4534","LU0792757196.USD","LU0795875086.SGD","LU0640476718.USD","BK4581","LU0203345920.USD","LU0889566641.SGD","LU1221951129.SGD","LU2430703178.SGD","LU1778281490.HKD","IE00BDGV0183.EUR","LU0882574055.USD","JNJ","LU1732800096.USD","BK4504"],"gpt_icon":0},{"id":"2522384330","title":"Rybrevant® (Amivantamab-Vmjw) Plus Lazcluze™ (Lazertinib) Outperforms Osimertinib With a Significant and Unprecedented Overall Survival Benefit in Patients With Egfr-Mutated Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2522384330","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522384330?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q91BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889566641.SGD","LU1732800096.USD","LU1196500208.SGD","BK4568","BK4581","IE00B42XCP33.USD","LU1221951129.SGD","LU2347655156.SGD","LU0114720955.EUR","LU1894683264.USD","LU1066051811.HKD","IE00BVYPNW00.USD","LU2430703178.SGD","LU0203345920.USD","LU1074936037.SGD","LU2129689514.USD","LU0792757196.USD","LU1732799900.SGD","BK4534","LU0203347892.USD","LU0795875086.SGD","IE00B2B36J28.USD","JNJ","LU0234572021.USD","LU0795875169.SGD","LU1066051225.USD","IE00BFTCPJ56.SGD","BK4550","LU0058720904.USD","LU1267930813.SGD","BK4504","LU1066051498.USD","LU1061106388.HKD","LU1430594728.SGD","LU0466842654.USD","LU1778281490.HKD","LU2505996681.GBP","LU0345770993.USD","IE0009355771.USD","IE00BDGV0183.EUR","SG9999002224.SGD","LU0345770308.USD","LU0640476718.USD","BK4532","LU0882574055.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","LU0098860793.USD","LU1585245621.USD","BK4592"],"gpt_icon":0},{"id":"2522380315","title":"RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2522380315","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522380315?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003900,"startTime":"0","endTime":"0","summary":"Median overall survival not yet reached with projected improvement of more than one year versus osimertinib. At a median follow-up of 37.8 months, patients treated with the chemotherapy-free regimen of first-line RYBREVANT plus LAZCLUZE had a significantly longer OS compared to those receiving osimertinib . Median OS for RYBREVANT plus LAZCLUZE has not yet been reached, indicating that survival benefits continue to extend beyond the measured follow-up period . Comparatively, median OS for osimertinib-treated patients was 36.7 months  and consistent with prior studies with osimertinib. Fifty-six percent of patients treated with RYBREVANT and LAZCLUZE were alive at three and a half years compared to 44 percent of patients on osimertinib. Projections based on survival data suggest RYBRE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/rybrevant-amivantamab-vmjw-plus-lazcluze-154500938.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rybrevant-amivantamab-vmjw-plus-lazcluze-154500938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) outperforms osimertinib with a significant and unprecedented overall survival benefit in patients with EGFR-mutated non-small cell lung cancer","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ"],"gpt_icon":0},{"id":"2522803973","title":"Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522803973","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522803973?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:40","pubTimestamp":1742996410,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Why Investors Should Pay Attention to This Value Stock. Different than growth or momentum investors, value-focused investors are all about finding good stocks at good prices, and discovering which companies are trading under what their true value is before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to help pick out the most attractive and discounted stocks.Johnson & Johnson  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-johnson-johnson-jnj-134010452.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJT1NW94.SGD","LU0203347892.USD","LU2089984988.USD","IE000M9KFDE8.USD","LU1585245621.USD","LU0320765646.SGD","IE00B2B36J28.USD","LU0345769128.USD","IE00B1BXHZ80.USD","LU1061106388.HKD","LU0122379950.USD","LU2430703251.USD","LU0345769631.USD","LU1267930813.SGD","LU2347655156.SGD","BK4504","IE0002270589.USD","LU1244550577.SGD","LU1778281490.HKD","LU2430703178.SGD","LU1057294990.SGD","LU1732799900.SGD","LU0203345920.USD","LU0345770993.USD","LU2468319806.SGD","LU0792757196.USD","SG9999001440.SGD","IE00BVYPNW00.USD","LU0466842654.USD","LU1894683348.USD","LU0795875086.SGD","IE0009355771.USD","LU1066051225.USD","LU1032466523.USD","JNJ","LU1914381329.SGD","LU2602419157.SGD","LU0114720955.EUR","LU0098860793.USD","SG9999002232.USD","BK4532","LU2129689431.USD","SG9999002224.SGD","LU0795875169.SGD","LU1074936037.SGD","LU0889566641.SGD","LU0289739699.SGD","LU0882574055.USD","LU1732800096.USD","BK4007"],"gpt_icon":0},{"id":"2522383156","title":"These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar","url":"https://stock-news.laohu8.com/highlight/detail?id=2522383156","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522383156?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:00","pubTimestamp":1742994005,"startTime":"0","endTime":"0","summary":"Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure helps cut through all the noise.The earnings figure itself is key, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb even higher.The final step today is to look at a stock that meets our ESP qualifications. Centene  earns a Zacks Rank #3 30 days from its next quarterly earnings release on April 25, 2025, and its Most Accurate Estimate comes in at $2.29 a share.CNC is just one of a large group of Medical stocks with a positive ESP figure. Johnson & Johnson  is another qualifying stock you may want to consider.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2-medical-stocks-could-beat-130005899.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNC","JNJ"],"gpt_icon":0},{"id":"2522741628","title":"BRIEF-New Nipocalimab Data And Real-World Research At Aan 2025 Highlight Positive Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis (gMG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522741628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522741628?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:04","pubTimestamp":1742990658,"startTime":"0","endTime":"0","summary":"BRIEF-New Nipocalimab Data And Real-World Research At Aan 2025 Highlight Positive Phase 3 Results And Commitment To People Living With Generalized Myasthenia Gravis (gMG)March 26 (Reuters) - Johnson &","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA1D31CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU0345769128.USD","BK4592","IE0009355771.USD","LU1585245621.USD","LU2347655156.SGD","LU0058720904.USD","LU1935042991.SGD","IE0034235303.USD","BK4532","IE00B3PB1722.GBP","LU2430703178.SGD","LU1732800096.USD","LU1894683264.USD","IE00B19Z3B42.SGD","IE00B1BXHZ80.USD","LU0122379950.USD","LU0795875086.SGD","LU2129689514.USD","LU0289739699.SGD","LU0466842654.USD","LU0345770308.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1221951046.USD","LU1914381329.SGD","LU2592432038.USD","LU0203347892.USD","BK4585","JNJ","LU1032466523.USD","LU1066053197.SGD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","IE0002270589.USD","LU1778281490.HKD","LU1674673428.USD","SG9999002232.USD","LU0320765646.SGD","LU1221951129.SGD","LU1718418525.SGD","LU0792757196.USD","IE00BVYPNV92.GBP","LU1261432733.SGD","LU2129689605.HKD","IE00BDGV0183.EUR","LU1929549753.HKD","LU1196500208.SGD","LU1244550221.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2522874150","title":"New Nipocalimab Data and Real-World Research at Aan 2025 Highlight Positive Phase 3 Results and Commitment to People Living With Generalized Myasthenia Gravis (Gmg)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522874150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522874150?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:03","pubTimestamp":1742990583,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA1D31CC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0034235303.USD","LU2430703178.SGD","LU0122379950.USD","IE00BVYPNV92.GBP","BK4585","IE00B4R5TH58.HKD","LU1585245621.USD","BK4592","LU0795875086.SGD","JNJ","LU2129689605.HKD","LU1778281490.HKD","SG9999002232.USD","IE00BDGV0183.EUR","IE00B19Z3B42.SGD","LU1914381329.SGD","LU1221951129.SGD","BK4532","LU2592432038.USD","LU0203347892.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","LU2129689514.USD","LU0466842654.USD","LU1032466523.USD","LU1244550221.USD","LU0058720904.USD","LU0792757196.USD","LU1929549753.HKD","LU1674673428.USD","LU1732800096.USD","IE0002270589.USD","LU0098860793.USD","LU0345769128.USD","IE00BJJMRZ35.SGD","LU1261432733.SGD","LU1894683264.USD","LU1935042991.SGD","SG9999002224.SGD","LU1221951046.USD","IE0009355771.USD","LU1066053197.SGD","IE00B1BXHZ80.USD","LU2347655156.SGD","LU0289739699.SGD","LU1718418525.SGD","LU0320765646.SGD","LU1196500208.SGD","LU0345770308.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2522804933","title":"New nipocalimab data and real-world research at AAN 2025 highlight positive Phase 3 results and commitment to people living with generalized myasthenia gravis (gMG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522804933","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522804933?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:03","pubTimestamp":1742990580,"startTime":"0","endTime":"0","summary":"Oral presentation features new data from the 24-week pivotal Vivacity-MG3 study which show sustained disease control through treatment with nipocalimab on the clinician-assessed QMGa score in antibody positive adult patients: anti-AChR+, anti-MuSK+, anti-LRP4+. Nipocalimab data demonstrate longer-term sustained disease control as measured by MG-ADLb and QMG scores from the ongoing open-label extension  of the Vivacity-MG3 study. Johnson & Johnson filed a Biologics License Application  for nipocalimab in August 2024 and was granted U.S. FDA Priority Review for the treatment of gMG. Real-world studies highlight the unmet need of patients living with gMG, including those who are pregnant or receiving steroids. Oral and poster presentations include data from the pivotal Phase 3 Vivacity-MG3 study of nipocalimab in gMG, which was included in the U.S. Biologics License Application  for nipocalimab:. Data evaluating nipocalimab using the clinician-administered QMGa assessment score demonstrat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nipocalimab-data-real-world-research-120300965.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nipocalimab-data-real-world-research-120300965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1506573853.SGD","LU0345770308.USD","LU1066051498.USD","LU1914381329.SGD","LU1935042991.SGD","LU2129689514.USD","PT","IE00BGHQF631.EUR","LU0345770993.USD","IE00BFTCPJ56.SGD","LU2347655156.SGD","IE00BMQBXF63.USD","LU1894683264.USD","LU2129689605.HKD","AAN","IE00BMG7P694.USD","IE00BVYPNW00.USD","LU1066051811.HKD","BK4581","LU0795875169.SGD","LU2592432038.USD","BK4534","IE00B7SZL793.SGD","LU2112291526.USD","LU1244550494.USD","IE00B7SZLL34.SGD","LU0203345920.USD","IE00B3PB1722.GBP","JNJ","LU0320765646.SGD","LU1221951046.USD","LU1066053197.SGD","LU1929549753.HKD","LU2129689431.USD","LU0466842654.USD","LU0912757837.SGD","MG","LU2505996681.GBP","LU1244550221.USD","IE00BSNM7G36.USD","LU0289739699.SGD","BK4568","D","OCS","LU1162221912.USD","IE00B19Z4B17.USD","IE00BZ18W340.USD","IE00B42XCP33.USD","IE00BJJMRZ35.SGD","IE00BMG7P819.SGD"],"gpt_icon":0},{"id":"2522889098","title":"Press Release: Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2522889098","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522889098?lang=en_us&edition=fundamental","pubTime":"2025-03-26 01:11","pubTimestamp":1742922660,"startTime":"0","endTime":"0","summary":"Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan. WARREN, N.J., March 25, 2025  -- Tevogen Bio  , a clinical-stage specialty immunotherapy biotech company leveraging AI-driven immunotherapy drug discovery, today announced the appointment of David E. Banko, CPA, a leading expert with three decades of industry experience in market access and health policy, to its leadership team as Global Head of Government Affairs and Patient Access.Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature's most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies to treat infectious disease and cancers, aiming to address the significant unmet needs of large patient populations. Tevogen Bio leadership believes that sustainability and commercial success in the c","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE00B3PB1722.GBP","BK4139","LU0098860793.USD","LU1267930813.SGD","LU1244550494.USD","LU2129689514.USD","SG9999001440.SGD","TVGN","LU1430594728.SGD","IE00BVYPNW00.USD","LU1023059063.AUD","LU2592432038.USD","LU1244550577.SGD","LU0795875086.SGD","LU2505996681.GBP","BK4504","IE00BSNM7G36.USD","LU1066051811.HKD","LU1221951129.SGD","IE00B42XCP33.USD","LU1718418525.SGD","LU2430703251.USD","BK4581","LU0466842654.USD","IE0009355771.USD","LU0882574055.USD","LU1585245621.USD","BK4585","LU0203347892.USD","LU0795875169.SGD","LU2430703178.SGD","IE0034235303.USD","LU0114720955.EUR","LU2505996509.AUD","IE0002270589.USD","BK4559","LU0792757196.USD","LU1894683264.USD","LU1261432733.SGD","IE000M9KFDE8.USD","LU2112291526.USD","BK4588","LU0203345920.USD","SG9999002232.USD","BK4550","IE00B1BXHZ80.USD","JNJ","LU2468319806.SGD","LU0912757837.SGD"],"gpt_icon":0},{"id":"2522226400","title":"Johnson & Johnson Medtech Launches Dualto™ Energy System for Use Across Surgical Treatment Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=2522226400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522226400?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:02","pubTimestamp":1742904131,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q8054:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2430703095.HKD","LU0345769631.USD","LU1718418525.SGD","LU1244550494.USD","LU0912757837.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU1914381329.SGD","LU1057294990.SGD","LU1674673691.USD","LU0882574055.USD","LU1894683264.USD","LU1066051225.USD","LU1066051811.HKD","LU1244550221.USD","IE00B2B36J28.USD","JNJ","LU1162221912.USD","BK4550","LU1929549753.HKD","LU0345770308.USD","BK4533","LU0289739699.SGD","IE00BDGV0183.EUR","IE00BVYPNV92.GBP","IE0002270589.USD","LU1196500208.SGD","LU2592432038.USD","LU1732800096.USD","IE00BFTCPJ56.SGD","BK4585","LU1244550577.SGD","LU1430594728.SGD","LU0345770993.USD","IE00BGHQF631.EUR","LU2468319806.SGD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU0889566641.SGD","IE00B19Z3B42.SGD","LU0795875086.SGD","LU2430703251.USD","LU1261432733.SGD","SG9999002224.SGD","IE00B3PB1722.GBP","LU2430703178.SGD","LU2112291526.USD","LU2505996681.GBP","LU1061106388.HKD"],"gpt_icon":0},{"id":"2522602896","title":"AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522602896","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522602896?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:00","pubTimestamp":1742900400,"startTime":"0","endTime":"0","summary":"AC Immune to host symposium highlighting the company’s industry-leading pipeline of active immunotherapies for precision prevention of neurodegenerative diseases. Multiple presentations at the International Conference on Alzheimer’s and Parkinson’s Disease  showcasing the diversity of the company’s precision medicine pipeline. Lausanne, Switzerland, March 25, 2025 – AC Immune SA , a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the International Conference on Alzheimer’s and Parkinson’s Diseases  taking place in Vienna, Austria, on April 1 – 5, 2025. AC Immune will host an industry symposium highlighting advances in the clinical development of active immunotherapies featuring key opinion leaders, industry experts and AC Immune leadership.Opening and Closing Remarks: Andrea Pfeifer, Ph.D., CEO of AC Immune. Targeting alpha-synuclein in early","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ac-immune-announces-upcoming-presentations-110000252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","LU0098860793.USD","LU1244550577.SGD","LU1585245621.USD","LU2133065610.SGD","ACIU","LU1935042991.SGD","LU1162221912.USD","PD","BK4581","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","LU0122379950.USD","LU2129689514.USD","IE00B19Z3581.USD","IE00BGHQF631.EUR","LU0345770308.USD","LU0203345920.USD","BK4533","SG9999002224.SGD","LU1914381329.SGD","LU1674673691.USD","LU2592432038.USD","LU0795875169.SGD","BK4585","JNJ","LU1032466523.USD","LU0234572021.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1023059063.AUD","LU1267930813.SGD","LU1732799900.SGD","AC","IE0002270589.USD","LU1280957306.USD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU1066051225.USD","LU0640476718.USD","BK4550","LU2468319806.SGD","BK4559","IE00BVYPNV92.GBP","LU2505996509.AUD","IE00BDGV0183.EUR","LU1169589451.USD","LU1244550221.USD","LU1244550494.USD","BK4135"],"gpt_icon":0},{"id":"2522044612","title":"FACTBOX-How companies are responding to Trump's tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2522044612","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522044612?lang=en_us&edition=fundamental","pubTime":"2025-03-25 18:29","pubTimestamp":1742898566,"startTime":"0","endTime":"0","summary":"FACTBOX-How companies are responding to Trump's tariffsAdds Hyundai Motor Group's investment plans","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3N3Q80KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0302445910.USD","LU0964807845.USD","LU2089984988.USD","LU0672654240.SGD","JNJ","SG9999000418.SGD","LU0784385840.USD","AA","LU1548497426.USD","IE00BFTCPJ56.SGD","LU2077746001.SGD","COST","LU2347655156.SGD","LU1914381329.SGD","LU0882574139.USD","TGT","LU2357305700.SGD","SG9999014575.USD","LU2452424414.USD","LU0203345920.USD","SGXZ81514606.USD","LLY","IE00BKVL7J92.USD","LU0957791311.USD","IE000M9KFDE8.USD","LU2210149790.SGD","MACW.SI","BK4579","LU1868837136.USD","LU2237443622.USD","LU1868837300.USD","IE00B3PB1722.GBP","SG9999018865.SGD","SG9999014906.USD","IE0008368304.USD","LU1935042215.USD","HPE","LU1037948897.HKD","LU1235294995.USD","LU1585245621.USD","IE00BJLML261.HKD","LU1803068979.SGD","IE00B1XK9C88.USD","LU2092627202.USD","BK4007","KR","BBY"],"gpt_icon":1},{"id":"2522808983","title":"3 amazing ASX ETFs for beginner investors to buy and hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2522808983","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522808983?lang=en_us&edition=fundamental","pubTime":"2025-03-25 06:02","pubTimestamp":1742853763,"startTime":"0","endTime":"0","summary":"Starting your investment journey can feel overwhelming, but exchange-traded funds  make it easier. Rather than picking individual stocks, ASX ETFs allow you to own a diversified portfolio of companies with just one trade. This reduces risk and simplifies investing—perfect for beginners!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/25/3-amazing-asx-etfs-for-beginner-investors-to-buy-and-hold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["SH","XKO.AU","XJO.AU","ESmain","CSL.AU","IVV.AU","USJW.SI","NVD3.UK",".IXIC","SPY","SSO","JNJ","SNVD.UK","OEF","NVDD","MNQmain","QID","QLD","SPXU","NVDY","SDS","XAO.AU","FDN","IVV","TSYW.SI","VOO","USAW.SI","MACW.SI","SQQQ","NVDX","PSQ","NQmain","WES.AU","AQLT.AU","NVDS","MQG.AU","NVD2.UK","NVDU","NDQ.AU","NVDS.UK","OEX","NVIW.SI","NVD"],"gpt_icon":1},{"id":"2522880410","title":"ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522880410","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522880410?lang=en_us&edition=fundamental","pubTime":"2025-03-25 03:00","pubTimestamp":1742842800,"startTime":"0","endTime":"0","summary":"Shares of AC Immune ACIU have lost 18.3% in the past month compared with the industry’s decline of 1.3%. The stock has underperformed the sector and the S&P 500 Index during this timeframe.Earlier in the month, ACIU reported better-than-expected results for the fourth quarter. Nonetheless, shares of this Switzerland-based clinical-stage biopharmaceutical company continue to slide down.Let’s delve deeper and analyze the company’s strengths and weaknesses to understand how to play the stock in such a scenario.ACIU Underperforms Industry, Sector and S&P 500 Index. ACI-7104.056, an active immunotherapy targeting pathological a-syn, is currently being tested in the phase II study  in the EU and the UK.ACIU has collaborated with Janssen Pharmaceuticals, Inc., part of Johnson & Johnson JNJ, for ACI-35.030/JNJ-2056. In September 2024, the company received a milestone payment triggered by the rapid rate of prescreening in the potentially registrational phase IIb ReTain trial and the first patie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aciu-stock-crashes-18-3-190000479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889566641.SGD","LU1674673428.USD","SG9999002232.USD","BK4581","IE00B42XCP33.USD","BK4007","BK4559","LU0114720955.EUR","LU1066051811.HKD","BK4113","IE00B3PB1722.GBP","LU0203345920.USD","LU2133065610.SGD","LU2430703178.SGD","LU2129689514.USD","LU2430703251.USD","LU2468319806.SGD","BK4023","LU1732799900.SGD","BK4534","IE00B2B36J28.USD","BK4588","JNJ","LU0795875169.SGD","IE00BFTCPJ56.SGD","BK4550","ACIU","LU1935042991.SGD","LU1059921491.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU1674673691.USD","LU1066051498.USD","LU2505996509.AUD","PD","ACI","LU1061106388.HKD","LU1430594728.SGD","LU1221951046.USD","LU1778281490.HKD","IE0002270589.USD","IE0034235303.USD","IE00BDGV0183.EUR","SG9999002224.SGD","IE00BGHQF631.EUR","LU1162221912.USD","TAK","LU0882574055.USD","IE00B4R5TH58.HKD","LU1585245621.USD"],"gpt_icon":0},{"id":"2522707823","title":"Kenvue Faces Activist Pressure: TOMS Capital Management Pushes for Strategic Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707823","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707823?lang=en_us&edition=fundamental","pubTime":"2025-03-25 00:01","pubTimestamp":1742832114,"startTime":"0","endTime":"0","summary":"Kenvue (KVUE, Financial) is again under pressure from an activist investment firm, following earlier scrutiny from Starboard Value. TOMS Capital Management has acquired an undisclosed stake in KVUE an","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2748966/kenvue-faces-activist-pressure-toms-capital-management-pushes-for-strategic-changes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU1066051811.HKD","MMM","LU0466842654.USD","LU2089984988.USD","LU1244550577.SGD","LU0795875169.SGD","LU0345769631.USD","BK4532","BK4581","LU0289739699.SGD","LU1244550494.USD","LU1032955483.USD","LU1074936037.SGD","LU2430703251.USD","LU1430594728.SGD","LU2602419157.SGD","BK4512","IE00B2B36J28.USD","LU1066051225.USD","BK4568","JNJ","IE00B1BXHZ80.USD","BK4007","LU1059921491.USD","IE0002270589.USD","LU1093756168.USD","LU0114720955.EUR","LU2430703095.HKD","IE00B7SZLL34.SGD","SG9999002224.SGD","LU1506573853.SGD","IE00BDGV0183.EUR","LU1585245621.USD","LU0203347892.USD","LU0203345920.USD","IE00BSNM7G36.USD","LU0345770993.USD","IE00B42XCP33.USD","LU0882574055.USD","IE00B3PB1722.GBP","LU1261432733.SGD","LU0098860793.USD","LU1162221912.USD","LU2129689431.USD","LU1032466523.USD","LU1093756325.SGD","LU2129689605.HKD","LU0912757837.SGD","LU1267930813.SGD","BK4550"],"gpt_icon":0},{"id":"2521247217","title":"Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521247217","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521247217?lang=en_us&edition=fundamental","pubTime":"2025-03-24 21:14","pubTimestamp":1742822082,"startTime":"0","endTime":"0","summary":"We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Johnson & Johnson  stands against other best healthcare dividend stocks to invest in.The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry. The rise of telehealth, virtual consultations, and technological advancements has reshaped the way healthcare services are delivered.The healthcare sector faced a turbulent year in 2024. During the first half, investors gravitated toward industries such as technology and communication services, particularly those linked to the growing influence of AI, leaving healthcare stocks trailing behind. However, as the market rally broadened in the second half of the year, healthcare stocks saw some recovery, though certain segments continued to struggle with lingering supply-and-demand imbalances from the pandemic. Beyond these chal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-jnj-best-healthcare-131442794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","LU2592432038.USD","LU0289739699.SGD","LU2505996509.AUD","LU2133065610.SGD","LU0345770308.USD","LU0889566641.SGD","LU0795875169.SGD","LU1059921491.USD","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU1674673428.USD","LU1894683264.USD","LU1244550221.USD","LU1778281490.HKD","LU2112291526.USD","LU2129689431.USD","LU0466842654.USD","LU1066051811.HKD","BK4592","LU1430594728.SGD","IE00BVYPNV92.GBP","BK4585","LU0792757196.USD","IE00BSNM7G36.USD","BK4534","IE0034235303.USD","IE00B19Z3581.USD","SG9999001440.SGD","LU1057294990.SGD","LU0882574055.USD","LU2347655156.SGD","SG9999002224.SGD","GDP","LU2430703178.SGD","IE0002270589.USD","JNJ","LU1066051498.USD","LU0114720955.EUR","LU1261432733.SGD","LU0203347892.USD","LU2129689605.HKD","LU2430703251.USD","LU0320765646.SGD","LU1221951129.SGD","LU1066051225.USD","BK4559","IE00B3PB1722.GBP","HCSG","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2521288547","title":"Market Chatter: Kenvue Urged by TOMS Capital to Consider Sale, Spinoff of Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2521288547","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521288547?lang=en_us&edition=fundamental","pubTime":"2025-03-24 20:20","pubTimestamp":1742818811,"startTime":"0","endTime":"0","summary":"Kenvue  is being urged by investor TOMS Capital Investment Management to consider selling the company or spinning off some of its assets, Bloomberg reported Monday.TOMS Capital has been accumulating shares in the company that was spun out of Johnson & Johnson  in 2023, the report said, citing sources with knowledge of the matter.Kenvue  and TOMS Capital Investment did not immediately respond to requests for comment from MT Newswires.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0792757196.USD","LU2505996681.GBP","LU0882574055.USD","BK4532","LU1221951129.SGD","LU1244550221.USD","IE00B3PB1722.GBP","LU0289739699.SGD","LU1280957306.USD","IE00B19Z3581.USD","LU0122379950.USD","LU1894683264.USD","IE00B4R5TH58.HKD","LU0098860793.USD","BK4533","IE00B42XCP33.USD","IE00B7SZLL34.SGD","BK4504","LU1585245621.USD","BK4183","LU1032955483.USD","SG9999001440.SGD","BK4559","LU0203345920.USD","IE00BSNM7G36.USD","LU1894683348.USD","LU1732800096.USD","IE0009355771.USD","LU2430703095.HKD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2592432038.USD","LU2129689605.HKD","LU0345770308.USD","LU0058720904.USD","JNJ","KVUE","IE00B1BXHZ80.USD","LU0234570918.USD","LU2430703178.SGD","LU2505996509.AUD","LU1244550577.SGD","LU0320765646.SGD","LU1059921491.USD","LU1929549753.HKD","LU1267930813.SGD","LU1778281490.HKD","IE00BGHQF631.EUR","LU1914381329.SGD","BK4550"],"gpt_icon":0},{"id":"2521830728","title":"Here's How to Play JNJ Stock as it Announces $55B US Investment Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2521830728","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521830728?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:31","pubTimestamp":1742812260,"startTime":"0","endTime":"0","summary":"Last week, J&J JNJ announced plans to invest more than $55 billion over the next four years to expand its manufacturing footprint in the United States as the Trump administration considers imposing tariffs on pharmaceuticals.This represents a 25% increase in investmentcompared to the previous four years. The investments begin with the groundbreaking of a high-tech facility in North Carolina. In addition, the company will build three new advanced manufacturing facilities and expand several existing plans across its Innovative Medicine and MedTech businesses.The massive U.S. investments shift focus to J&J stock. However, investors should not make their investment decisions based on just on-off news. Let’s analyze the company’s strengths and weaknesses to gain a better understanding of how to play the stock.J&J lost U.S. patent exclusivity of its blockbuster drug, Stelara, in 2025. Stelara generated sales of $10.36 billion in 2024. The launch of generics is expected to significantly erode","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-play-jnj-stock-announces-103100843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2430703095.HKD","LU1718418525.SGD","LU1244550494.USD","LU2602419157.SGD","IE0002141913.USD","LU1585245621.USD","IE00B7SZLL34.SGD","BK4559","IE00BSNM7G36.USD","LU1057294990.SGD","LU1066051498.USD","LU0882574055.USD","LU1674673691.USD","BK4568","LU1066051225.USD","LU1221951129.SGD","LU2129689431.USD","LU1778281490.HKD","LU0889565916.HKD","BK4581","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","JNJ","LU2505996509.AUD","KVUE","LU0234570918.USD","BK4533","LU0203347892.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2592432038.USD","LU1032466523.USD","IE00BFTCPJ56.SGD","BK4585","LU0792757196.USD","LU1430594728.SGD","SG9999001440.SGD","IE00B42XCP33.USD","LU2242652126.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU0053671581.USD","ITCI","LU0203345920.USD","SG9999002224.SGD","LU0320765992.SGD","LU2430703178.SGD","LU2112291526.USD","LU1061106388.HKD","AMGN"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":16,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2025-05-27","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-27","defaultRemindTime":1748352600000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-27","currency":"USD","dateTimestamp":1748318400000,"payDate":"2025-06-10"},{"market":"US","date":"2025-04-15","symbol":"JNJ","fiscalQuarterEnding":"2025/03","expectedEps":2.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"pre","actualEps":2.77},{"date":"2025-02-18","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-18","defaultRemindTime":1739889000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-04","payableDate":"2025-02-18","currency":"USD","dateTimestamp":1739854800000,"payDate":"2025-03-04"},{"market":"US","date":"2025-01-22","symbol":"JNJ","fiscalQuarterEnding":"2024/12","expectedEps":2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"pre","actualEps":2.04},{"date":"2024-11-26","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-26","defaultRemindTime":1732631400000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-26","currency":"USD","dateTimestamp":1732597200000,"payDate":"2024-12-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-21","recordDate":"2015-05-26","paymentDate":"2015-06-09","value":0.75,"currency":"USD"},{"executeDate":"2015-08-21","recordDate":"2015-08-25","paymentDate":"2015-09-08","value":0.75,"currency":"USD"},{"executeDate":"2015-11-20","recordDate":"2015-11-24","paymentDate":"2015-12-08","value":0.75,"currency":"USD"},{"executeDate":"2016-02-19","recordDate":"2016-02-23","paymentDate":"2016-03-08","value":0.75,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1923,"buy":0.2692,"hold":0.5385,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2692,"analysts":26,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2025-04-25","current":17.091836,"percent":0.187344,"low":8.579006,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"high":36.412821,"avg":22.732897,"sd":6.732846,"marketCap":372772933115},"quantilePoints":[{"date":"2020-05-01","current":22.759176,"twenty":18.735775,"median":23.109347,"eighty":27.599044,"marketCap":390684023595},{"date":"2020-05-08","current":22.822102,"twenty":19.127953,"median":23.109347,"eighty":27.599044,"marketCap":391764207354},{"date":"2020-05-15","current":23.089153,"twenty":19.382974,"median":23.109347,"eighty":27.599044,"marketCap":396348401845},{"date":"2020-05-22","current":22.157545,"twenty":19.475347,"median":23.109347,"eighty":27.599044,"marketCap":380356413017},{"date":"2020-05-29","current":22.829776,"twenty":19.5115,"median":23.109347,"eighty":27.599044,"marketCap":391895937081},{"date":"2020-06-05","current":22.607234,"twenty":19.590503,"median":23.109347,"eighty":27.599044,"marketCap":388075775005},{"date":"2020-06-12","current":21.816825,"twenty":19.649079,"median":23.109347,"eighty":27.599044,"marketCap":374507613150},{"date":"2020-06-19","current":22.074667,"twenty":19.775373,"median":23.109347,"eighty":27.599044,"marketCap":378933731969},{"date":"2020-06-26","current":21.150732,"twenty":19.950076,"median":23.109347,"eighty":27.599044,"marketCap":363073472868},{"date":"2020-07-02","current":21.635721,"twenty":19.98339,"median":23.109347,"eighty":27.599044,"marketCap":371398791598},{"date":"2020-07-10","current":21.85059,"twenty":20.011787,"median":23.109347,"eighty":27.599044,"marketCap":375087223947},{"date":"2020-07-17","current":25.912196,"twenty":20.076078,"median":23.131106,"eighty":27.599044,"marketCap":393476693802},{"date":"2020-07-24","current":25.681516,"twenty":20.125159,"median":23.159117,"eighty":27.599044,"marketCap":389973813117},{"date":"2020-07-31","current":25.272331,"twenty":20.149539,"median":23.193752,"eighty":27.599044,"marketCap":383760349716},{"date":"2020-08-07","current":25.764739,"twenty":20.181909,"median":23.222825,"eighty":27.599044,"marketCap":391237568385},{"date":"2020-08-14","current":25.702321,"twenty":20.22081,"median":23.257402,"eighty":27.599044,"marketCap":390289751934},{"date":"2020-08-21","current":26.486013,"twenty":20.241265,"median":23.27709,"eighty":27.599044,"marketCap":402190114041},{"date":"2020-08-28","current":26.638591,"twenty":20.271241,"median":23.306845,"eighty":27.599044,"marketCap":404506998699},{"date":"2020-09-04","current":25.763006,"twenty":20.293663,"median":23.353075,"eighty":27.599044,"marketCap":391211240150},{"date":"2020-09-11","current":25.622565,"twenty":20.348379,"median":23.394637,"eighty":27.599044,"marketCap":389078653135},{"date":"2020-09-18","current":25.865302,"twenty":20.493086,"median":23.413631,"eighty":27.599044,"marketCap":392764606000},{"date":"2020-09-25","current":25.254993,"twenty":20.589134,"median":23.432295,"eighty":27.599044,"marketCap":383497067368},{"date":"2020-10-02","current":25.355555,"twenty":20.66024,"median":23.457245,"eighty":27.599044,"marketCap":385024104984},{"date":"2020-10-09","current":26.175658,"twenty":20.718013,"median":23.519753,"eighty":27.599044,"marketCap":397477360020},{"date":"2020-10-16","current":22.955443,"twenty":20.777568,"median":23.52089,"eighty":27.599044,"marketCap":389921156647},{"date":"2020-10-23","current":22.509743,"twenty":20.802059,"median":23.52089,"eighty":27.599044,"marketCap":382350497681},{"date":"2020-10-30","current":21.249731,"twenty":20.852405,"median":23.52089,"eighty":27.599044,"marketCap":360947925757},{"date":"2020-11-06","current":22.046344,"twenty":20.90683,"median":23.52089,"eighty":27.599044,"marketCap":374479195092},{"date":"2020-11-13","current":23.231964,"twenty":20.932588,"median":23.52089,"eighty":27.599044,"marketCap":394618146532},{"date":"2020-11-20","current":22.683324,"twenty":20.94836,"median":23.52089,"eighty":27.599044,"marketCap":385298945473},{"date":"2020-11-27","current":22.317564,"twenty":20.961808,"median":23.52089,"eighty":27.599044,"marketCap":379086144768},{"date":"2020-12-04","current":23.289308,"twenty":20.97761,"median":23.52089,"eighty":27.599044,"marketCap":395592187321},{"date":"2020-12-11","current":23.704663,"twenty":21.021529,"median":23.531213,"eighty":27.599044,"marketCap":402647401682},{"date":"2020-12-18","current":23.946436,"twenty":21.042546,"median":23.534826,"eighty":27.599044,"marketCap":406754168250},{"date":"2020-12-24","current":23.630271,"twenty":21.070826,"median":23.548153,"eighty":27.599044,"marketCap":401383781199},{"date":"2020-12-31","current":24.391238,"twenty":21.097347,"median":23.558663,"eighty":27.599044,"marketCap":414309565719},{"date":"2021-01-08","current":24.803493,"twenty":21.111621,"median":23.586469,"eighty":27.599044,"marketCap":421312129226},{"date":"2021-01-15","current":24.843788,"twenty":21.147258,"median":23.595957,"eighty":27.599044,"marketCap":421996590321},{"date":"2021-01-22","current":25.347483,"twenty":21.183404,"median":23.599747,"eighty":27.599044,"marketCap":430552354005},{"date":"2021-01-29","current":29.186264,"twenty":21.19897,"median":23.614272,"eighty":30.081908,"marketCap":429446686083},{"date":"2021-02-05","current":29.422431,"twenty":21.226117,"median":23.637028,"eighty":30.081908,"marketCap":432921642410},{"date":"2021-02-12","current":29.803518,"twenty":21.248794,"median":23.655744,"eighty":30.081908,"marketCap":438528958301},{"date":"2021-02-19","current":29.159427,"twenty":21.257145,"median":23.669632,"eighty":30.081908,"marketCap":429051804682},{"date":"2021-02-26","current":28.309134,"twenty":21.271585,"median":23.6918,"eighty":30.081908,"marketCap":416540604911},{"date":"2021-03-05","current":27.887517,"twenty":21.285637,"median":23.70506,"eighty":30.12771,"marketCap":410336920526},{"date":"2021-03-12","current":28.556475,"twenty":21.311821,"median":23.72791,"eighty":30.12771,"marketCap":420179968572},{"date":"2021-03-19","current":28.635202,"twenty":21.329473,"median":23.741859,"eighty":30.12771,"marketCap":421338359462},{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115}],"updateTime":1745668655290}}}